Science and Research

Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib

  • Kauffmann-Guerrero, D.
  • Kahnert, K.
  • Kumbrink, J.
  • Syunyaeva, Z.
  • Tufman, A.
  • Huber, R. M.

Keywords

  • Concomitant driver mutations
  • Epithelial growth factor receptor
  • Next generation sequencing
  • Non small cell lung cancer
  • TKI combination
Publication details
DOI: 10.1016/j.cllc.2018.09.009
Journal: Clinical lung cancer
Work Type: Original
Location: CPC-M
Disease Area: LC
Partner / Member: LMU
Access-Number: 30341016
See publication on PubMed

DZL Engagements

chevron-down